logo
Share SHARE
FONT-SIZE Plus   Neg

NeoStem Names Robert Dickey IV As CFO - Quick Facts

NeoStem Inc. (NBS: Quote) announced that it has appointed Robert Dickey IV as Chief Financial Officer, effective today.

NeoStem stated that Larry May, the company's long-time Chief Financial Officer, is assuming the newly-created position of Vice President, Strategic Initiatives, and will assist Dickey in the transition as well as focus on the company's various strategic activities.

Dickey has over 15 years of management experience at life sciences companies, including positions as a CFO, COO and CEO and board member, following a career as an investment banker.

He has specific expertise in financing, M&A, partnering/licensing transactions and project management, as well as international experience.

Dickey is joining NeoStem from Hemispherx Biopharma, Inc. where he served as Senior Vice President. Prior to Hemispherx , Dickey was Senior Vice President, Chief Financial Officer and Business Unit Manager at StemCyte Inc. Other management experience includes leadership positions at Protarga Inc, and Locus Pharmaceuticals. Previously, he spent 18 years as an investment banker, 14 of those at Lehman Brothers, with a background split between M&A and capital markets transactions across a variety of industries.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
If calories are not reduced, exercise alone can have no effect on obesity, says British Sports Medicine, a peer-reviewed journal of sport and exercise medicine. The journal says the blame for expanding waist lines is directly on the type and amount of calories consumed and the poor diet generates more disease than physical inactivity, alcohol and smoking combined. Deutsche Bank (DB) on Sunday reported an about 50 percent decline in first-quarter profit, despite clocking double-digit revenue growth, as the German lender recorded hefty legal charges over allegations of rate-rigging. Casino operator Wynn Resorts said its shareholders ousted Elaine Wynn from the board, reflecting fears that her presence may lead to disharmony with the management.
comments powered by Disqus
Follow RTT